Panitumumab added to 5-FU/LV effective as maintenance therapy in patients with mCRC Presented ByProf. Dominik Modest, Charité Universitätsmedizin Berlin, Germany TrialPhase 3, PANAMA ConferenceASCO 2021 12 August, 2021 22:34